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Cyclic di-GMP (c-di-GMP) plays an important role in bacterial adaptation to enable survival in
changing environments. It orchestrates various pathways involved in biofilm formation, changes in
the cell surface, host colonization and virulence. In this article, we report the presence of c-di-
GMP in Mycobacterium smegmatis, and its role in the long-term survival of the organism. M.
smegmatis has a single bifunctional protein with both GGDEF and EAL domains, which show
diguanylate cyclase (DGC) and phosphodiesterase (PDE)-A activity, respectively, in vitro. We
named this protein MSDGC-1. Deletion of the gene encoding MSDGC-1 did not affect growth
and biofilm formation in M. smegmatis, but long-term survival under conditions of nutritional
starvation was affected. Most of the proteins that contain GGDEF and EAL domains have been
demonstrated to have either DGC or PDE-A activity. To gain further insight into the regulation of
the protein, we cloned the individual domains, and tested their respective activities. MSDGC-1,
the full-length protein, is required for activity, as its GGDEF and EAL domains are inactive when
separated.
INTRODUCTION
The social behaviour of bacteria is increasingly being
understood, and it appears that cell–cell communication or
quorum sensing among bacteria plays a very important
role in maintenance and survival of organisms. However,
the most interesting aspect of quorum sensing is the
coordinated response of bacteria; this confers multi-
cellularity to the bacterial population, and generates
responses such as biofilm formation, antibiotic production,
sporulation, virulence factor expression, etc. (Miller &
Bassler, 2001). Second messengers play an important role
in relaying extracellular information, and cAMP and
ppGpp are two well-known examples of second messengers
(Chatterji & Ojha, 2001; Camilli & Bassler, 2006; Shenoy &
Visweswariah, 2006). Another interesting nucleotide deriv-
ative, cyclic di-GMP (c-di-GMP), has been found to be
involved in modulating cell surface and biofilm formation
in several bacteria. This molecule was first reported about
20 years ago in Gluconacetobacter xylinus (formerly
Acetobacter xylinum), as a positive allosteric regulator of
cellulose synthase (Ross et al., 1987; Weinhouse et al., 1997;
Tal et al., 1998). The derivative c-di-GMP is formed by the
condensation of two GTP molecules, and it is hydrolysed
to GMP via a linear intermediate, pGpG. The synthesis and
breakdown of c-di-GMP is regulated by diguanylate cyclase
(DGC) and phosphodiesterase (PDE) encoded by GGDEF
and EAL domains, respectively. The GGDEF conserved
motif forms the catalytically active site in DGC, and
mutations in these conserved residues have resulted in
reduced activity of the protein (Paul et al., 2004; Christen
et al., 2005). On the other hand, EAL domain proteins
degrade c-di-GMP to pGpG, the linear intermediate, which
is further hydrolysed to two GMP molecules by another
presumably ubiquitous enzyme, PDE-B (Chan et al., 2004;
Schmidt et al., 2005; Tamayo et al., 2005). Interestingly,
another family of proteins, the HD–GYP-domain proteins,
has recently been shown to degrade c-di-GMP to GMP in
Xanthomonas (Ryan et al., 2006).
In recent years, c-di-GMP has been implicated in different
biological processes in bacteria (for reviews, see Jenal &
Malone, 2006; Tamayo et al., 2007). An increased level of c-
di-GMP has been found to stimulate matrix (exopolysac-
charide/cellulose) production, and hence biofilm forma-
tion, and to regulate the transition between motile and
sessile forms (Simm et al., 2004). Various studies have
demonstrated a clear link between the level of c-di-GMP
and alterations in cell-surface properties, motility and
Abbreviations: c-di-GMP, cyclic di-GMP; DGC, diguanylate cyclase; PDE,
phosphodiesterase.
Figures showing data from MALDI-TOF MS analysis for detection and
identification of c-di-GMP and pGpG, genotype confirmation for the
deletion of MSDGC-1, biofilm formation in the DMSDGC-1 knockout
strain, and declumping of a M. smegmatis culture, and a table listing the
primers used in the present study are available with the online version of
this paper.
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biofilm formation in bacteria (D’Argenio et al., 2002;
Kirillina et al., 2004; Tischler & Camilli, 2004; Hickman et
al., 2005; Behyan et al., 2006; Kazmierczak et al., 2006;
Kuchma et al., 2007; Merritt et al., 2007). Similarly, the role
of c-di-GMP in the surface attachment, cell cycle and
development of Caulobacter crescentus has been demon-
strated elegantly by the research group of Jenal (Aldridge et
al., 2003; Paul et al., 2004) and others (Huitema et al.,
2006). c-di-GMP has also been implicated in the regulation
of virulence in bacterial pathogens. Tischler & Camilli
(2005) were the first to demonstrate that c-di-GMP
regulates the expression of virulence factors in Vibrio
cholerae. The ability of V. cholerae to form a biofilm, and its
colonization in the host, are governed by a c-di-GMP-
mediated switch (Tamayo et al., 2007). An EAL domain in
Salmonella controls bacterial survival in mice by resisting
the host phagocyte oxidase (Hisert et al., 2005). Several
other studies have indicated a role for c-di-GMP in the
virulence of different bacteria, such as Pseudomonas
aeruginosa (Kuchma et al., 2005; Kulasakara et al., 2006),
Xanthomonas campestris (Beyhan et al., 2006), Brucella
melitensis (Lestrate et al., 2003) and Bordetella pertussis
(Merkel et al., 1998). However, most of the studies
demonstrating the role of c-di-GMP in various physio-
logical aspects have been carried out in Gram-negative
bacteria. In Gram-positive organisms, the only studies
carried out so far have been with Staphylococcus aureus, and
these have revealed that treatment with extracellular c-di-
GMP inhibits cell–cell interaction and biofilm formation in
a dose-dependent manner (Karaolis et al., 2005; Brouillette
et al., 2005).
Like most other bacterial genera, the genus Mycobacterium
includes both pathogens and saprophytes. The pathogenic
species include Mycobacterium tuberculosis and
Mycobacterium leprae, which cause tuberculosis and
leprosy, respectively. These diseases are serious health
problems: one-third of the population of the world is
infected by tubercle bacilli. Unfortunately, M. leprae does
not grow in vitro, and M. tuberculosis has a doubling time
of 24 h; therefore, it is difficult to develop effective drugs
against these organisms. Also, latent bacilli can persist in
the host for years in an ill-defined physiological state, and
become reactivated when the host is immunocompromised
(Bloom & Murray, 1992). The development of effective
drugs against such highly adaptive pathogens requires a
better understanding of their physiology. Many mycobac-
terial species, including Mycobacterium avium,
Mycobacterium fortuitum, Mycobacterium marinum and
Mycobacterium smegmatis, form biofilms, although it is
unclear whether M. tuberculosis is able to form a biofilm
(Hall-Stoodley et al., 2004; Ojha & Hatfull, 2007). The
biofilms have high resistance towards commonly used
drugs (Teng & Dick, 2003). As described earlier, c-di-GMP
plays an important role in biofilm formation and
adaptation in several bacterial species; however, to the best
of our knowledge, the presence of c-di-GMP has not been
reported in mycobacteria.
When we searched for GGDEF and EAL domains,
important signatures were obtained in all the mycobacterial
species for which genome sequences are available. M.
smegmatis, a non-pathogenic fast-growing species, has been
widely accepted as an excellent model system for studying
various aspects of M. tuberculosis biology (Jacobs et al.,
1987; Smeulders et al., 1999; Ojha et al., 2000; Dahl et al.,
2005). To understand the physiological role of c-di-GMP
in mycobacteria, we cloned, overexpressed and knocked
out the GGDEF–EAL domain protein of M. smegmatis. We
report here thatM. smegmatis encodes a protein containing
GAF, GGDEF and EAL domains in tandem. We named this
protein MSDGC-1, and demonstrate that it is able to
synthesize and degrade c-di-GMP in vitro. Deletion of the
gene encoding MSDGC-1 affects the long-term survival of
bacteria under conditions of nutritional starvation.
Further, full-length MSDGC-1 is required for both DGC
and PDE-A activity, as isolated GGDEF and EAL domains
have no detectable biological activities.
METHODS
Bacterial strains, plasmids and growth conditions. Plasmids and
oligonucleotides used in this study are listed in Table 1 and Table S1
(available with the online version of this paper). Escherichia coli
strains DH5a and BL21 (DE3) were grown in Luria–Bertani (LB)
broth at 37 uC, with agitation, or on LB medium containing 1.5%
(w/v) agar. M. smegmatis mc2155 was grown in MB7H9 (Difco) broth
with 2% (w/v) glucose as the carbon source, and 0.05% (v/v) Tween
80, or on MB7H9 medium containing 1.5% (w/v) agar. Antibiotics
were used at the following concentrations, as and when required
(mg ml21): ampicillin (100), kanamycin (35) or gentamicin (20) for
E. coli, and kanamycin (20), gentamicin (10) or hygromycin (30) for
M. smegmatis. PCRs were carried out using Dynazyme EXT
polymerase (Finnzyme), following the manufacturer’s instructions.
All clones generated were confirmed by sequencing (Microsynth).
Restriction enzymes used for cloning were obtained from New
England Biolabs.
Bioinformatics analysis. A search of the M. smegmatis genome for
the annotation of proteins containing GGDEF and EAL domains was
carried out using the TIGR database (http://cmr.jcvi.org/tigr-scripts/
CMR/CmrHomePage.cgi). Two ORFs, MSMEG_2196 and
MSMEG_2774, were annotated as putative GGDEF and EAL domain
proteins. The protein sequence was subjected to Smart database (v4.0;
http://smart.embl-heidelberg.de/) and NCBI Conserved Domains
database (v2.13; www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi)
searches to identify the various domains present in the protein.
Furthermore, we did a BLAST analysis of the GGDEF and EAL domains
in a non-redundant NCBI database to find protein homologues in
other mycobacteria.
Cloning, expression and purification of MSDGC-1 and MSDGC-
2. GenesMSMEG_2196 (1848 bp, 615 aa) andMSMEG_2774 (1080 bp,
359 aa) were PCR-amplified from M. smegmatis genomic DNA using
primersmkf andmkr, andMKDGCF andMKDGCR, respectively (Table
S1). The amplicons MSMEG_2196 and MSMEG_2774 were cloned into
the plasmid pET21b usingNheI–NotI and NdeI–HindIII restriction sites,
respectively. Vector pET28a was used for N-terminal His6-tag cloning of
MSMEG_2774. The resulting plasmids pET DGC_2196, pET DGC_2774
and pET DGC_2774 Nter were transformed into E. coli BL21 (DE3) for
protein expression. Protein purificationwas done as described (Jain et al.,
2006b). Briefly, cells were induced with IPTG, harvested, and lysed in
c-di-GMP and long-term survival in M. smegmatis
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lysis buffer containing 50 mM Tris/Cl (pH 7.9), 500 mM NaCl and
1 mM PMSF. After centrifugation, the lysate was loaded onto an Ni-
NTA column, and washed with 100 column vols wash buffer containing
10 mM imidazole. The protein was eluted with elution buffer containing
500 mM imidazole, dialysed against a buffer containing 50 mM Tris/Cl
(pH 7.9) and 500 mM NaCl, and stored at 4 uC for future use.
Cloning, expression and purification of GAF, GGDEF and EAL
domains of MSDGC-1. For the construction of GAF (aa 23–166),
GGDEF (aa 175–334) and EAL (aa 348–590), pET DGC_2196 was
used as a template, and primers mkGAF (F) and mkGAF (R),
mkGGDEF (F) and mkGGDEF (R), and mkEAL (F) and mkEAL (R)
(Table S1) were used, respectively. For the amplification of GGDEF–
EAL, primers mkGGDEF (F) and mkEAL (R) were used. The required
region was PCR amplified, and cloned into the pET21b vector at NheI
and HindIII sites, thus resulting in pGAF, pGGDEF, pEAL and
pGGDEF-EAL. N-terminal His6-tag cloning was done using pET28a
vector digested with the same set of restriction enzymes. For
expression and purification of the protein, the strategy was similar
to that used for the full-length protein, as described above.
Enzymic assays. DGC and PDE-A assays were adapted from
procedures described by others (Christen et al., 2005). The reaction
mixtures with purified proteins MSDGC-1 or MSDGC-2, or PleD
protein, contained 25 mM Tris/HCl, pH 7.8, 250 mM NaCl and
10 mM MgCl2 in a 50 ml volume, and the reactions were started by
the addition of a mixture of 0.1 mM GTP and [a-32P]GTP
[0.01 mCi ml21 (370 Bq ml21); BRIT]. Aliquots were withdrawn at
regular time intervals, and the reaction was stopped by the addition of
an equal volume of 50 mM EDTA. Reaction products (2.5 ml) were
separated on polyethyleneimine-cellulose plates (Merck) in 1 : 1.5
(v/v) (NH4)SO4 and 1.5 M KH2PO4 (pH 3.6), and plates were
exposed to a phosphor-imager screen. [a-32P]-labelled c-di-GMP,
prepared as described below, was used as the substrate for
determination of PDE-A activity.
Preparation of [32P]c-di-GMP and cold c-di-GMP. The protocol
used was adapted from that described by Christen et al. (2005) for the
preparation of [a-32P]-labelled and non-labelled c-di-GMP. For
radiolabelled c-di-GMP, [a-32P]GTP [125 mCi (4.625 MBq); 3500 Ci
mmol21 (129.5 TBq mmol21)] was incubated with 100 mg purified
His6-tagged PleD protein. The soluble fraction of the E. coli cell lysate
(100 mg) was used as a negative control. The protein was precipitated
by placing it in boiling water for 5 min, followed by centrifugation,
and filtration through a 0.02 mM filter. The supernatant was tested for
the presence of c-di-GMP by TLC, and used further without
purification. Non-labelled c-di-GMP was prepared by using 1 mM
GTP as a substrate, and purified by HPLC, as described (Simm et al.,
2004). The identity of c-di-GMP was confirmed by MALDI-TOF MS.
Overexpression of MSDGC-1. The gene MSMEG_2196 was sub-
cloned into the E. coli–Mycobacterium shuttle vector pMV261 (Stover et
al., 1991) using primers RELCO F and RELCOR (see Table S1), resulting
in pMVDGC_2196. This vector was electroporated into M. smegmatis
mc2155, and colonies were selected on MB7H9 medium containing
kanamycin. Growth in liquid culture was followed by plating declumped
bacteria onto MB7H9 agar plate containing 2% (w/v) glucose as the
carbon source. Bacterial clumping was minimized by vortexing the cells
with 0.5 mm glass beads, as described (Primm et al., 2000).
Targeted replacement of MSMEG_2196 in M. smegmatis
mc2155. A recombination cassette was constructed to delete
MSMEG_2196 from the chromosome of M. smegmatis mc2155
(Table 1). The cassette consisted of a 3.2 kb DNA fragment spanning
from base 246 upstream of MSMEG_2196 to base 750 of
MSMEG_2196, and a fragment spanning from base 1175 of
MSMEG_2196 to base 321 downstream of MSMEG_2196, with an
EcoRI fragment holding the aph gene from vector pUC4K between
them. After the preparative cloning steps, the whole recombination
cassette was transferred to the suicide vector pPR27 to obtain the final
construct pDGCKO. M. smegmatis mc2155 was transformed with
pDGCKO. The sucrose-resistant, gentamicin-sensitive and kanamy-
cin-resistant colonies were selected for further analysis. The
disruption of the gene, and the recombination event, were verified
by Southern hybridization and PCR in selected colonies. For PCR, the
primers used were mkGGDEF (F) and mkEAL (R) and KO-F and
Table 1. Strains and plasmids used in this study
Strain or plasmid Characteristics Source or reference
M. smegmatis mc2155 Parental strain This study
DMSDGC-1 M. smegmatis in which MSMEG_2196 is replaced with a Kan
r cassette This study
M smeg pMV M. smegmatis transformed with pMV261 vector alone, Kanr This study
M smeg pMV2196 M. smegmatis transformed with pMVDGC_2196, Kanr This study
MSDGC-1 complement DMSDGC-1 complemented with MSMEG_2196, Kanr Hygr This study
pUC4K Source of aph gene Pharmacia Biotech
pET21b Cloning vector (C-terminal His6 tag), Amp
r Novagen
pET28a Cloning vector (N-terminal His6 tag), Amp
r Novagen
pPR27 Suicide vector, Genr Pelicic et al. (1997)
pMV261 Cloning vector with hsp60 promoter, Kanr Stover et al. (1991)
pMV complement MSDGC-1 cloned in pMV361, Hygr This study
pMV361 Cloning vector with hsp60 promoter, Hygr Stover et al. (1991)
pMVDGC_2196 MSDGC-1 cloned in pMV261, Kanr This study
pET DGC_2196 MSDGC-1 cloned in pET21b, Ampr This study
pET DGC_2774 MSDGC-2 cloned in pET21b, Ampr This study
pET DGC_2774 Nter MSDGC-2 cloned in pET28a, Kanr This study
pGAF GAF domain of MSDGC-1 cloned in pET21b, Ampr This study
pGGDEF GGDEF domain of MSDGC-1 cloned in pET21b, Ampr This study
pEAL Nter EAL domain of MSDGC-1 cloned in pET28a, Kanr This study
pGGDEF-EAL GGDEF–EAL domain of MSDGC-1 cloned in tandem This study
M. Kumar and D. Chatterji
2944 Microbiology 154
KO-R (Table S1). For Southern hybridization, the genomic DNA of
the putative mutant, as well as that of mc2155, was digested with
PvuII. The probe used was a fragment of approximately 1.8 kb DNA
from MSMEG_2196, and it was labelled with [a-32P]ATP by using the
Random Primer Labelling kit (Bangalore Genei), following the
protocol of the manufacturer.
Western blot analysis. Western blot analysis for detection of
MSDGC-1 was carried out with primary antibodies raised in rabbit
against the purified His6-tagged protein. Proteins extracted from cells
grown for different lengths of time were normalized, separated by
SDS-PAGE, and blotted onto a PVDF membrane. The polyclonal sera
were diluted by a factor of 2000 before use, and secondary antibodies
were purchased from Sigma Aldrich. The blots were developed with
26 mg aminoethylcarbazole ml21 and 0.01% (v/v) H2O2. The a
subunit of RNA polymerase was used as an internal control.
Isolation and detection of c-di-GMP from M. smegmatis. The
cells were grown in MB7H9 with 2.0% (w/v) glucose, and then
harvested and washed. Nucleotides were extracted by acid, as
described (Weinhouse et al., 1997). Briefly, cells were incubated on
ice with 0.6 M HClO4, and extracts were neutralized with 5 M
K2CO3. Samples were centrifuged to remove the precipitate of KClO4,
and the supernatant was lyophilized. Lyophilized extracts were
resuspended in HPLC buffer A (see below), and subjected to HPLC
separation. Purified c-di-GMP, as described above, was used as a
standard, and peak area was used for quantification.
HPLC analysis and MS. Samples (20 ml) were injected onto a C-18
column (25064.6 cm; Supelco), and separated by reverse-phase
HPLC (Agilent 1100). Buffer A (100 mM KH2PO4, and 4 mM
tetrabutyl ammonium hydrogen sulfate, pH 5.9) and buffer B [75%
(v/v) buffer A and 25% (v/v) methanol] were used in the gradient
programme, as described by Ryjenkov et al. (2005). Nucleotides were
detected at the wavelength of 254 nm. For MS, samples were diluted
1 : 10 in a solution containing10 mg dihydroxybenzoic acid ml21,
0.1% (v/v) trifluoroacetic acid, and 50% (v/v) acetonitrile. A total of
1 ml was spotted onto a MALDI-TOF MS plate, and the samples were
analysed in reflectron and positive-ion modes with an Ultraflex TOF-
TOF mass spectrometer (Bruker Daltonics). The resulting spectra
were calibrated using the standard calibration kit provided by the
manufacturer.
Long-term starvation cultures. DMSDGC-1, the wild-type strain of
M. smegmatis mc2155, and the complemented strain, were grown in
MB7H9 containing 0.02% (w/v) glucose and 0.05% (v/v) Tween 80
until saturation. The antibiotics were omitted from the culture to rule
out any possible effect that they might have had on long-term
survival. In the knockout strain and the complemented strain, the
antibiotic marker was integrated chromosomally, and therefore it was
not lost. Bacterial cultures were declumped before plating on agar, as
described earlier. The number of c.f.u. was determined at regular
intervals of time up to 20 days.
Biofilm formation assay. The biofilm formation assay was
performed as described (Mathew et al., 2006). Cultures grown to
stationary phase were diluted 1 : 100 to inoculate 30 ml Sauton’s
medium in 90 mm diameter polystyrene Petri dishes, and the
formation of surface pellicles was observed. For quantification of
biofilm formation, the method described by O’Toole et al. (1999) was
adapted. Experiments were started from a culture of bacteria grown in
Sauton’s medium. This culture was then diluted to a final OD600 of
0.05 in Sauton’s medium, and distributed into 96-well polystyrene
plates at time zero. Each well received an inoculum of 200 ml, and 10
wells were assayed for each strain at each time point. The samples
were removed from the wells, and the wells were washed twice with
water. The adherent film was stained with 1% crystal violet, and
incubated for 45 min at room temperature. The residual dye was
washed thoroughly with water, and the plate was allowed to dry. The
bound dye was solubilized in 300 ml 80% (v/v) ethanol, and A550 was
measured using a microtitre plate reader.
RESULTS
Identification of GGDEF and EAL domain-
containing proteins in M. smegmatis
The domain organization of sequences MSMEG_2196 and
MSMEG_2774 was obtained from the Smart database, as
depicted in Fig. 1. For convenience, we named the sequences
MSDGC-1 and MSDGC-2, respectively, and these names are
referred to throughout the text. When searching for GGDEF
and EAL domains in other mycobacterial species, we found
approximately 70 sequences containing either or both
GGDEF and EAL conserved domains. Representatives of
different domain architectures in various mycobacterial
proteins are depicted in Fig. 1. Table 2 lists the number of
proteins and their domain organization in different myco-
bacteria. Intriguingly, most mycobacterial species appear to
have at least one protein with GAF–GGDEF–EAL domain
organization (Fig. 1), except M. bovis BCG strain Pasteur,
whereas Mycobacterium gilvum PYR-GCK and Mycoba-
cterium vanbaalenii PYR-1 have the highest numbers of
these proteins among mycobacteria, i.e. 22 and 15,
respectively (Table 2). Proteins from different mycobacterial
species with GAF–GGDEF–EAL domain architecture share
.60% amino acid identity among themselves. We also
observed several sequences with a GGEEF motif, in which D
had been changed to E, and a few EAL domains withmutated
GGDEF domains in the N-terminal region. For example, M.
vanbaalenii PYR-1 has a protein with GGDEF and EAL
domains in which GGDEF is altered to QGDEF.
M. smegmatis MSDGC-1 is a bifunctional protein
in vitro
In order to study the DGC and PDE-A activity of MSDGC-
1 and MSDGC-2, the proteins were expressed in E. coli
BL21 (DE3) cells, and purified to homogeneity, as judged
by SDS-PAGE profiles (Fig. 2) and MS analysis (data not
shown). MSDGC-1 showed c-di-GMP synthesis and
degradation activity in vitro (Fig. 3). On the TLC plate,
the spot with the same Rf value as that of c-di-GMP was
apparently followed by another spot with the Rf of linear
di-GMP (pGpG). A reaction mixture containing PleD
protein (Paul et al., 2004), which is a known DGC protein
of C. crescentus, was used as a positive control, and E. coli
cell lysate was used as a negative control. For the
identification of the reaction products, the samples that
were not radioactively labelled were either directly analysed
by MALDI-TOF MS (Fig. S1, available with the online
version of this paper), or subjected to HPLC (Fig. 4),
followed by collection of peaks and analysis by MALDI-
TOF MS. The peak at 16.1 min had the same retention time
as that of GTP, and a prominent [M+H]+ at anm/z ratio of
c-di-GMP and long-term survival in M. smegmatis
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524 was detected. Similarly, the peak at 18.5 min had the
same retention time as that of purified c-di-GMP, and had
the identical m/z value at 691 [M+H]+. The HPLC fraction
at 16.4 min gave a signal at m/z 709 [M+H]+, and this
corresponded to the addition of a water molecule to c-di-
GMP (Fig. 4). This is in agreement with EAL having PDE
activity, which hydrolyses c-di-GMP to pGpG. Purified c-di-
GMP was prepared from PleD (Paul et al., 2004), and used
as a control. However, longer incubation times did not yield
GMP, thus indicating that only PDE-A activity was present.
N-terminal His6-tagged MSDGC-2 did not show c-di-GMP
synthesis in vitro (Fig. 3b).
Overexpression of MSDGC-1 alters the growth
rate and colony morphology
MSDGC-1 was subcloned in shuttle vector pMV261 under
the control of the heat shock promoter hsp60. We
Fig. 1. Representative domain architectures
of proteins with GGDEF and EAL motifs in
different species of mycobacteria. A protein
with the domain organization GAF–GGDEF–
EAL (MSDGC-1) is present in almost all
mycobacterial species (see Table 2 for
details). Domain symbols were taken from the
SMART database. Predicted transmembrane
regions are shown as rectangles. The number
of amino acids in the sequence is given in
parentheses. DUF1, GGDEF domain; DUF2,
EAL domain; RES, response regulator CheY-
like domain; GAF, cGMP-specific PDE, aden-
ylyl cyclases and FhlA domain; PAS,
Drosophila period clock, aryl hydrocarbon
receptor and single-minded proteins domain.
Table 2. Proteins with GGDEF and EAL domains in different mycobacterial species
Organism (total no. of
proteins with GGDEF
and/or EAL domains)
Domain organization
GAF–GGDEF–
EAL
GGDEF–
EAL
GGDEF* GGEEFD EAL EAL with
degenerate
GGDEF
Otherd
M. smegmatis mc2155 (2) 1 – 1 – –
M. bovis BCG Pasteur (1) – – – – 1 –
M. tuberculosis H37 Rv (2) 1 – – – 1 –
M. tuberculosis CDC1551 (1) 1 – – – – –
M. leprae TN (4) 1 – 1 – 1 – PAS–GGDEF–
AraH
Mycobacterium sp. JLS (4) 1 1 – 2 – –
Mycobacterium sp. MCS (8) 2 2 – 4 – –
M. avium 104 (7) 2 – 4 1 – –
M. avium subsp. paratubercu-
losis K-10 (5)
1 – 2 – 1 1
M. vanbaalenii PYR-1 (15) 1 1 2 8 1 1 GAF–EAL–PAS–
GGDEF
M. gilvum PYR-GCK (22) 1 4 3 10 1 2 GAF–EAL–PAS–
GGDEF
*GGDEF domain with one or more input sensory domain, such as PAS, Rec, FlhA or GAF.
DGGDEF domain with GGEEF conserved motif.
dDomain organization that is unusual in its arrangement, having EAL on the N-terminal side of GGDEF, and an AraH output domain inM. leprae.
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compared the growth of the MSDGC-1-overexpressing
strain with that of the wild-type in MB7H9 broth
supplemented with 2% (w/v) glucose and 0.05% (v/v)
Tween 80. It can be seen from Fig. 5(a) that the
overexpressing strain grew at a slower rate than the wild-
type. On solid agar medium, the overexpressing strain
showed a different colony morphology compared with the
control, which was the wild-type containing the vector only
(Fig. 5b). The normal colony of M. smegmatis had a non-
uniform margin, rugose surface, and comparatively very
large size, whereas the overexpressing strain had a uniform
margin, smooth surface and round shape, and was smaller
in size.
Deletion of MSDGC-1 affects the long-term
survival of M. smegmatis under conditions of
nutritional starvation
To establish the role of MSDGC-1 in the physiology of M.
smegmatis, the gene MSMEG_2196 was deleted by allelic
exchange. In the suicidal vector pPR27, the conserved
regions of GGDEF and EAL of MSDGC-1 were replaced
with a kanamycin-resistance marker. The advantage of
using a pPR27-based construct was the ability of the
plasmid to replicate at low temperatures only. This allows
the bacteria to undergo recombination during growth at
30 uC (Pelicic et al., 1997). Subsequent selection for
kanamycin-resistant, sucrose-resistant colonies at 39 uC, a
temperature at which the plasmid cannot replicate,
produces the double cross-over recombinant only.
Colonies were further tested by PCR and Southern
hybridization for confirmation of the knockout event.
We obtained an amplicon size of 1.2 kb in the wild-type,
and 2.0 kb in the knockout strain DMSDGC-1 (Fig. S2,
available with the online version of this paper). In Southern
hybridization, the probe hybridized to fragments of
approximately 3.9 kb and 0.5 kb in the parental strain,
and fragments of approximately 4.7 kb and 0.5 kb in the
knockout strain. The increase in the latter strain resulted
from the 800 bp increase in size of the region produced by
insertion of the kanamycin cassette (Fig. S2).
Fig. 2. Purification of His6-tagged proteins. Lanes: 1, marker; 2,
MSDGC-1; 3, MSDGC-2; C-terminal His6-tagged MSDGC-1 is
approximately 67 kDa, and N-terminal His6-tagged MSDGC-2 is
approximately 50 kDa. The purity of the preparations was deter-
mined by SDS-PAGE, and the gels were stained with Coomassie
brilliant blue. Molecular mass (kDa) is shown on the left.
Fig. 3. (a)M. smegmatis protein MSDGC-1 has both DGC and PDE-A activities. Purified His6-tagged protein was assayed for
the ability to synthesize c-di-GMP. The protein (5 mM) was incubated with assay buffer containing [a-32P]GTP, as described in
Methods. Samples were withdrawn at different time points, and analysed on polyethyleneimine-cellulose TLC. PleD, which is a
known DGC protein from C. crescentus, was used as a positive control. GTP in assay buffer without protein was run as a
control (g). (b) A similar protocol was followed for MSDGC-2, and c-di-GMP synthesis was not observed. (c) The soluble
protein fraction of E. coli cell extract (100 mg) was used as a negative control.
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M. smegmatis has only one protein that is predicted to
contain a GGDEF–EAL domain; therefore, the resulting
knockout strain should be without c-di-GMP (c-di-
GMP0). To test this feature, we analysed the total
nucleotide extract from the wild-type and DMSDGC-1 by
using HPLC coupled with MALDI-TOF MS. At 18.5 min, a
sharp peak corresponding to c-di-GMP was observed in
wild-type extracts, whereas no signal was observed in
DMSDGC-1 (Fig. 6). Further, we collected these fractions,
and identified them as c-di-GMP by using MALDI-TOF
MS (data not shown).
When we checked DMSDGC-1 for its ability to form a
biofilm, we did not observe any difference as compared
Fig. 4. Detection of c-di-GMP and pGpG by HPLC analysis. A DGC reaction mixture without protein (a), with MSDGC-1 (b),
and with purified c-di-GMP (c), was separated by reverse-phase HPLC (see Methods). Right, MALDI-TOF MS analysis of
relevant HPLC fractions (GTP, c-di-GMP and pGpG, as indicated by arrows in a, b and c, respectively) In the positive-ion
detection mode, major ions were detected at m/z values of: 524 [M+H]+ and 562 [M+K]+ for GTP; 691 [M+H]+ and 729
[M+K]+ for c-di-GMP; and 709 [M+H]+ and 747 [M+K]+ for pGpG.
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with the wild-type strain (Fig. S3, available with the online
version of this paper). Also, growth in planktonic culture,
and sliding motility on the soft agar, remained unchanged
in the knockout strain (data not shown). Further, we tested
the ability of the mutant to survive under long-term
starvation of the carbon source. It can be observed from
Fig. 7 that the culture of the knockout strain had 100-fold
less viable bacteria compared with that of the wild-type
when grown in MB7H9 medium containing 0.02% (w/v)
glucose and 0.05% (v/v) Tween 80. Bacterial cultures were
declumped before plating to minimize errors in counting
caused by clumping (Fig. S4, available with the online
version of this paper). However, it could be argued that
this phenotype was caused by the polar effect of the
disruption of MSDGC-1, and not by the loss of function of
the gene. To rule out this possibility, we complemented the
DMSDGC-1 strain with the functional gene through the
Fig. 5. Overexpression of MSDGC-1 alters the growth and colony
morphology of M. smegmatis. (a) The cultures were grown in
MB7H9 with 2% (w/v) glucose and 0.05% (v/v) Tween 80. The
arrow indicates the time point when cultures were shifted to 42 6C
for induction. m, Wild-type containing pMV261 vector (control);
#, strain overexpressing MSDGC-1. The values represent the
mean (±SD) of two independent experiments done in triplicate. (b)
When cultured on agar, the strain overexpressing MSDGC-1
produced small, round, smooth colonies, whereas M smegmatis
mc2155 wild-type strain (WT) produced large colonies with
irregular margins and a rough surface.
Fig. 6. The DMSDGC-1 knockout strain is a c-di-GMP0 strain.
The cells were grown for 72 h in MB7H9 medium with 2% (w/v)
glucose, and then centrifuged. The total nucleotides extracted from
M. smegmatis mc2155 (b), DMSDGC-1 (c), and the MSDGC-1
complemented strain (d), were run on reverse-phase HPLC.
Purified c-di-GMP was run as control (a). The relevant portions of
the chromatograms are shown. The fractions corresponding to c-
di-GMP peak (indicated by arrows) were collected, and analysed
by MALDI-TOF MS to confirm their identity.
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pMV361 vector containing MSDGC-1, and observed the
reversal of the mutant phenotype (Fig. 7).
The level of c-di-GMP increases in the stationary
phase of growth
The level of c-di-GMP in bacteria varies depending on the
environmental conditions, and the phase of growth. We
determined the level of MSDGC-1 production and c-di-
GMP concentration in three phases of growth, i.e.
exponential, early stationary and late stationary (Fig. 8a).
Whole-cell lysates of M. smegmatis mc2155 were separated
on SDS-PAGE, and analysed by Western blot using
polyclonal antibodies, which had been raised against
MSDGC-1 in rabbit. As expected, an immunoreactive
protein band, approximately 67 kDa in size (Fig. 8b), was
detected, with increased band intensity in stationary-phase
samples. The amount of MSDGC-1 was about three times
higher in stationary-phase samples compared with that in
exponential-phase samples. We also measured the levels of
c-di-GMP in the samples. Larger amounts of cells (3 g wet
weight) were used to extract the total nucleotide, and the
samples were subsequently run on HPLC. The peak with
the same retention time as standard c-di-GMP was
collected, and identified by MALDI-TOF MS. The peak
areas were plotted for comparison, and the results were in
agreement with an increased level of the protein MSDGC-1
in stationary-phase samples. The early- and late-stationary-
phase cultures had (mean±SD) relative peak areas of
0.85±0.25 and 1.90±0.18, respectively, which indicated
that they contained levels of c-di-GMP that were 1.3 and
3.1 times greater, respectively, than that of the exponential-
phase culture (relative peak area 0.60±0.16).
The full-length protein is required for DGC and
PDE-A activity
The protein MSDGC-1 is a three-domain protein, with
GGDEF and EAL domains in tandem with the N-terminal
GAF domain, and it possesses both DGC and PDE-A
activity. The GAF (cGMP, adenylyl cyclase, FhlA) domain
is a cyclic nucleotide (cGMP)-binding domain present in
PDE (Hurley, 2003). To understand the regulation of
MSDGC-1, we cloned the GAF, GGDEF and EAL
individually, and functionally characterized each one. We
were not able to overexpress and purify the GAF domain,
despite several attempts in which we cloned the domain in
both C- and N-terminal His6-tag orientations. The GGDEF
domain protein was purified by the addition of Triton X-
100 to the lysis buffer to improve its solubility. However,
the protein was partially contaminated with other proteins
(Fig. 9a), and we performed the DGC assay without further
purification of the protein. We did not observe a spot for c-
di-GMP on the TLC plate, and this indicated that the DGC
Fig. 7. DMSDGC-1 is not able to survive under conditions of
long-term starvation. Cultures were grown in MB7H9 medium with
0.02% (w/v) glucose and 0.05% (v/v) Tween 80. Aliquots were
withdrawn at different times after the culture had reached
stationary phase (48 h growth), and plated on MB agar containing
2% (w/v) glucose as the carbon source. The number of c.f.u. was
determined. m, Wild-type; h, DMSDGC-1; #, complemented
strain.
Fig. 8. The level of c-di-GMP increases in
stationary phase. (a) Growth curve of M.
smegmatis grown in MB7H9 with 2% (w/v)
glucose as the carbon source. Arrows indicate
the time points at which cells were harvested,
lysed, and used for Western blot analysis and
determination of the level of c-di-GMP. (b)
Western blot of whole-cell lysate probed with
antibody raised against MSDGC-1. The a
subunit of RNA polymerase (RpoA) was used
as an internal control because its level remains
unchanged in different phases of growth.
Purified MSDGC-1 and the cell lysate from
DMSDGC-1 were used as positive and
negative controls, respectively.
M. Kumar and D. Chatterji
2950 Microbiology 154
activity of the GGDEF domain was greatly reduced (Fig. 9b,
lane 2). Similarly, purification of the isolated EAL domain
yielded a partially purified protein that did not show PDE-
A activity (Fig. 9b, lane 5). Further, trans-complementation
or addition of one domain to the other separately, and
prolonged incubation, did not improve DGC or PDE-A
activity (data not shown). This indicates that the full-
length protein is required for both DGC and PDE-A
activities. One may argue that the full-length protein has
four cysteine residues distributed outside the GGDEF
domain, and that these may help in correct folding and
oligomerization of the protein, and hence the activity of the
isolated GGDEF domain was affected. It was clear that
correct folding of the full-length protein is important for
GGDEF–EAL activities, and that fused domains are
mandatory, from the observation that the presence of the
two domains in solution did not restore the catalytic
activity of either domain. It has also been suggested that
the GAF domain may help in binding to GTP (the
substrate) or c-di-GMP, and that it is required for the
activity of GGDEF. The combined GGDEF–EAL domain
showed poor DGC activity, and PDE-A activity was not
detected (Fig. 9b); this implies that the GAF domain is
important for the activity of the combined domain.
DISCUSSION
c-di-GMP has established itself in the ranks of secondary
messengers, such as cAMP and ppGpp, and it plays various
roles in microbial physiology. The number of pathways
being found to be influenced by this molecule in bacteria is
constantly increasing. Here, we present evidence that the
protein that can synthesize and degrade c-di-GMP is
present inM. smegmatis. Our study produced the following
experimental findings: (i) c-di-GMP is present in a Gram-
positive bacterium; (ii) the bacterium used in this study has
only one protein with a GGDEF–EAL domain; (iii) the
protein is bifunctional, having both DGC and PDE-A
activities. MSDGC-1 is a multidomain protein with GAF,
GGDEF and EAL domains in tandem. We would like to
note here that all known examples of composite GGDEF–
EAL proteins have either DGC or PDE activity, and from
the primary sequence it is difficult to predict the dominant
activity (Tal et al., 1998; Kazmierczak et al., 2006;
Kulasakara et al., 2006). However, it has been demon-
strated recently that proteins with GGDEF and EAL
domains can have both DGC and PDE activities, depend-
ing on the environmental conditions. For example, a full-
length bacteriophytochrome protein from Rhodobacter has
PDE activity, and the activity lies in the C-terminal EAL
domain; however, in the absence of an EAL domain, it
shows light-dependent DGC activity (Tarutina et al., 2006).
Similarly, ScrC, a GGDEF–EAL protein from Vibrio
parahaemolyticus, has intrinsic DGC and PDE activities,
and these activities are controlled by ScrAB. Primarily,
ScrC acts as PDE-A in the presence of ScrA and ScrB,
whereas it acts as DGC in the absence of ScrA and ScrB
(Ferreira et al., 2008).
It has been proposed that inactive domains containing a
deviation from the conserved motif have a regulatory role
(Ro¨mling et al., 2005; Jenal & Malone, 2006), or that they
could form a separate subclass of GGDEF domains (Pei &
Grishin, 2001). An example of this is the CC3396 protein of
C. crescentus, where the N-terminal domain has a
degenerated GGEEF motif that binds to GTP, which
allosterically controls the PDEA activity of the EAL domain
(Christen et al., 2005).
Fig. 9. DGC and PDE-A activity of GGDEF and EAL domains of
MSDGC-1. (a) Protein profiles, as eluted from an Ni-NTA column.
(b) The partially purified proteins were used for activity assays. The
assay buffer used for determining DGC contained GTP as the
substrate, whereas that for PDE activity contained 100 mM c-di-
GMP as the substrate. Labelled c-di-GMP was prepared by
incubating [a-32P]GTP with PleD, and it was used without
purification. Lanes: 1, control (assay buffer with GTP, without
protein); 2, GGDEF domain; 3, PleD protein; 4, c-di-GMP
(prepared as described above); 5, EAL domain; 6, GGDEF–EAL
domain; 7, full-length MSDGC-1.
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MSDGC-1 requires the presence of all the three domains,
and deletion of any single domain compromises its activity.
We were interested to find out how the opposing activities
in the same protein are regulated; therefore, it was
appropriate to make a comparison with the biosynthesis
of another second messenger, ppGpp, which is a stringent
factor. In Gram-negative organisms, two proteins, RelA
and SpoT, control the synthesis and degradation of ppGpp,
respectively, and maintain the level of ppGpp, which
interacts with RNA polymerase, and downregulates rRNA
synthesis under conditions of nutritional starvation
(Cashel et al., 1996). Apparently, the protein Rel, which
has RelA and SpoT in tandem, and a regulatory domain at
its C-terminal, manifests the intradomain interaction into
an opposing catalytic activity as a function of envir-
onmental conditions (Jain et al., 2006b). However, in the
case of MSDGC-1, in order to investigate the interdepen-
dence of the domains, we separated and functionally
identified each of the individual domains. We did not
detect the presence of c-di-GMP or pGpG as reaction
products when individual GGDEF and EAL domain
proteins were used. It was also noted that there was a
substantial reduction in DGC activity when the GGDEF–
EAL domains were in tandem.
The requirement of a neighbouring domain or the full-
length protein for the full activity has been reported by
others (Ryjenkov et al., 2005; Kazmierczak et al., 2006).
MSDGC-1 has a GAF domain that has not yet been studied
in the context of c-di-GMP, but it is believed to modulate
the activity of proteins with GGDEF–EAL domains by
binding to other molecules, such as cAMP, cGMP or c-di-
GMP. In single GGDEF domains investigated to date, the
presence of a GAF domain, or phosphorylation of the N-
terminal receiver domain, such as PAS, increases the
activity of the GGDEF domain (Paul et al., 2004; Ryjenkov
et al., 2005). Removal of the GAF domain from MSDGC-1
makes the protein inactive, and this suggests that the
protein has a role in regulation of c-di-GMP synthesis and
degradation. Mutational studies are underway to further
understand the mechanism of regulation.
Genes encoding proteins that contain GGDEF and EAL
domains are abundant in bacterial genomes, and they are
usually found along with genes encoding sensory or
regulatory domains, such as GAF and PAS, REC and
FlhA (Galperin et al., 2001). All mycobacterial species have
a homologue of MSDGC-1 (approx. 60% identity at the
amino acid level), and this suggests that the protein may
have a similar role to play in these species. Some species
have more than one protein containing a GGDEF–EAL
domain, and the need for more than one protein for the
modulation of c-di-GMP has been questioned for some
time. Studies done in different bacterial systems with
multiple numbers of these proteins have suggested that the
level of c-di-GMP is maintained in localized compartments
of the cell, and that it provides bacteria with the ability to
survive in different environmental niches in a specific
manner (Ro¨mling et al., 2005). This appears to be true for
some species of mycobacteria. For example, species such as
M. avium, which proliferate well in water and soil, and
aerosols and tissues of humans and animals, have a greater
number of proteins with the GGDEF–EAL domain
compared to M. smegmatis and M. tuberculosis. Other
mycobacterial species, such as M. gilvum and M. vanbaa-
lenii PYR-1, which have been isolated from polyaromatic
hydrocarbon bioremediation sites, have even greater
numbers of these proteins. This strongly suggests that c-
di-GMP could be involved in the survival and adaptation
of mycobacteria. In contrast to the well-studied models,
such as E. coli, Pseudomonas, Salmonella and Vibrio, M.
smegmatis has only one functional GGDEF–EAL domain.
Although we found two proteins with GGDEF–EAL
domains in the M. smegmatis genome, only one
(MSDGC-1) was enzymically active in our assay system.
MSDGC-2 (GGDEF domain, E value 2610212) has an
SDSEF amino acid sequence instead of the conserved
GGDEF, and this might result in a decrease in DGC
activity. However, in Shewanella oneidensis, the GGDEF
domain protein with the NVDEF motif has been demon-
strated to have DGC activity (Thormann et al., 2006).
Further, we did not detect c-di-GMP in the DMSDGC-1
strain, thus establishing that M. smegmatis has only one
enzymically active GGDEF–EAL domain. Recently, micro-
array studies on the M. smegmatis transcriptome in the
biofilm mode of growth, and in the stationary phase of
planktonic culture, have shown that MSDGC-2 is signifi-
cantly induced by fourfold in stationary phase and during
maturation of biofilms, as compared with the exponential-
growth phase (Ojha & Hatfull, 2007). At present, we do not
know what role MSDGC-2 plays in vivo, and how it helps
in maturation of biofilms.
An elevated intracellular level of c-di-GMP alters gene
expression, and modulates cell-surface properties, and this
leads to the formation of a biofilm and reduced motility
(Beyhan et al., 2006; Me´ndez-Ortiz et al., 2006). Studies by
those authors in E. coli and V. cholerae have revealed that, in
the presence of high levels of c-di-GMP, the genes
responsible for flagella synthesis, motility and chemotaxis
are repressed, and the genes for responsible exopolysacchar-
ide synthesis and membrane-associated genes are induced; it
has been found that most bacteria respond in the same
manner towards high levels of c-di-GMP, and exhibit a
similar phenotype. However, so far no information is
available in the literature regarding biofilm formation and
the intracellular level of c-di-GMP in Gram-positive bacteria.
Our data provide evidence that c-di-GMP has a role to play
in the long-term survival of bacteria under conditions of
nutritional starvation. It was surprising to find that the
growth of the knockout strain and wild-type strain was
comparable in liquid culture, and also that their ability to
form a biofilm was similar. We noticed that old cultures
from MB7H9 agar plates were difficult to revive, although
mycobacteria are well known for their long-term persist-
ence in stressful conditions, such as nutritional depriva-
tion, oxygen limitation and extreme pH; this persistence is
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often referred to as dormancy (Parrish et al., 1998;
Smeulders et al., 1999). Production of ppGpp, another
second messenger, is the hallmark of the stringent
response, and it plays a pivotal role in the persistence
and survival of bacteria (for a recent review see Jain et al.,
2006a). Studies have shown that ppGpp is required for the
long-term survival of M. tuberculosis, which is a pathogen
notorious for its persistence in the host under conditions of
prolonged starvation and anaerobiosis (Primm et al.,
2000).
Adaptation to the changing environment is key for the
survival of bacteria, and it is important to have a system
that can sense environmental fluctuations. The stationary
phase of bacterial cultures is a very useful system that
provides interesting information about bacterial adapta-
tion. Exhaustion of nutrients, accumulation of toxic
metabolites, and environmental stresses, such as low
temperature, change in pH and high osmolarity, are
factors that force bacterial entry into stationary phase.
Intriguingly, this growth phase has some striking features,
such as reduction of cell division, slowing down of
metabolic activity, increased resistance to stress, and
altered gene expression; these features enable adaptation
and survival. It can be argued that stationary-phase
conditions are closer to the conditions that the bacteria
encounter in the natural environment. Under such stressful
conditions, bacteria survive by producing spores, fruiting
bodies, etc. However, in the case of mycobacteria, altered
colony morphology and different staining properties have
been observed in conditions of nutritional starvation
(Nyka, 1974; Dahl et al., 2005). During stationary phase,
M. smegmatis forms clumps that increase in size during
prolonged starvation, and these may promote survival
(Smeulders et al., 1999). Similarly, P. aeruginosa forms cell
aggregates to survive in the presence of the toxic detergent
SDS, and formation of these aggregates is directly linked to
levels of c-di-GMP (Klebensberger et al., 2007). In our
experiments, we observed increased levels of c-di-GMP in
stationary phase, and this suggests that this second
messenger is important in adaptation, survival and
persistence.
A recent surge in research focusing on c-di-GMP has been
observed upon the realization that this molecule is present
in pathogens. Although the protein MSDGC-1 is from a
non-pathogen, it has homologues with .65% identity at
the amino acid level in pathogenic species such as M.
tuberculosis H37 Rv (1354c),M. leprae (NT01 3427) andM.
avium. It would be extremely useful to conduct experi-
ments to investigate the role of c-di-GMP in the persistence
and survival of mycobacterial pathogens.
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